{"transactions":[{"id":740081,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-13T00:00:13.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2026, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date."}],"balance_after":15500,"derivative":{"exercise_price":13.66,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001666963-26-000003","document":"form4-06122026_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000166696326000003/form4-06122026_080609.xml","form_type":"4"}},{"id":740080,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-13T00:00:13.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date."}],"balance_after":11750,"source":{"system":"sec-edgar","filing":"0001666963-26-000003","document":"form4-06122026_080609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000166696326000003/form4-06122026_080609.xml","form_type":"4"}},{"id":741693,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-06-11T16:30:13.000Z","date":"2026-06-10","kind":"sale","planned":true,"acquired":false,"shares":2026,"price":7.9137,"value":16033.1562,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.71 to $7.97. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 3,800 unvested RSUs subject to the grant's vesting schedule as previously reported."}],"balance_after":12140,"source":{"system":"sec-edgar","filing":"0001193125-26-267672","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000119312526267672/ownership.xml","form_type":"4"}},{"id":767999,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2026-05-21T17:07:10.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":12300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":12300,"derivative":{"exercise_price":9.15,"expiration_date":"2026-05-19","underlying":"Common Stock","underlying_shares":12300},"source":{"system":"sec-edgar","filing":"0001193125-26-234860","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000119312526234860/ownership.xml","form_type":"4"}},{"id":767998,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-05-21T17:07:10.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 19, 2026, 3,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 8,600 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":14166,"source":{"system":"sec-edgar","filing":"0001193125-26-234860","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000119312526234860/ownership.xml","form_type":"4"}},{"id":919408,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-04T20:41:12.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 25% on February 2, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":140000,"derivative":{"exercise_price":22.67,"expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001104659-26-010473","document":"tm265104-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000110465926010473/tm265104-2_4seq1.xml","form_type":"4"}},{"id":1111870,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-13T23:30:06.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date."}],"balance_after":11667,"derivative":{"exercise_price":25.46,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":11667},"source":{"system":"sec-edgar","filing":"0001415889-25-017310","document":"form4-06132025_070601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000141588925017310/form4-06132025_070601.xml","form_type":"4"}},{"id":1111869,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T23:30:06.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2026 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date."}],"balance_after":6250,"source":{"system":"sec-edgar","filing":"0001415889-25-017310","document":"form4-06132025_070601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000141588925017310/form4-06132025_070601.xml","form_type":"4"}},{"id":1127656,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2025-06-02T16:30:18.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":16000,"derivative":{"exercise_price":7.42,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000950170-25-080313","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000095017025080313/ownership.xml","form_type":"4"}},{"id":1127655,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-06-02T16:30:18.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 30, 2025, 4,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 10,366 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":10366,"source":{"system":"sec-edgar","filing":"0000950170-25-080313","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000095017025080313/ownership.xml","form_type":"4"}},{"id":1267306,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-14T16:24:52.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 25% on February 3, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":120000,"derivative":{"exercise_price":27.56,"expiration_date":"2035-02-03","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001104659-25-014164","document":"tm256714-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000110465925014164/tm256714-2_4seq1.xml","form_type":"4"}},{"id":1427651,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2024-08-20T16:48:47.000Z","date":"2024-08-16","kind":"grant","planned":false,"acquired":true,"shares":5566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":5566,"derivative":{"exercise_price":53.52,"expiration_date":"2034-08-16","underlying":"Common Stock","underlying_shares":5566},"source":{"system":"sec-edgar","filing":"0000950170-24-099175","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000095017024099175/ownership.xml","form_type":"4"}},{"id":1427650,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-08-20T16:48:47.000Z","date":"2024-08-16","kind":"grant","planned":false,"acquired":true,"shares":5566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 16, 2024, 5,566 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 5,566 unvested RSUs that were granted on August 16, 2024 and will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":5566,"source":{"system":"sec-edgar","filing":"0000950170-24-099175","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000095017024099175/ownership.xml","form_type":"4"}},{"id":1467312,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-28T20:30:45.000Z","date":"2024-06-26","kind":"grant","planned":false,"acquired":true,"shares":8350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal monthly installments over the 12 months following June 26, 2024, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date."}],"balance_after":8350,"derivative":{"exercise_price":39.8,"expiration_date":"2034-06-25","underlying":"Common Stock","underlying_shares":8350},"source":{"system":"sec-edgar","filing":"0001415889-24-018441","document":"form4-06282024_040641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000141588924018441/form4-06282024_040641.xml","form_type":"4"}},{"id":1467311,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-28T20:30:45.000Z","date":"2024-06-26","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 26, 2025 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001415889-24-018441","document":"form4-06282024_040641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000141588924018441/form4-06282024_040641.xml","form_type":"4"}},{"id":1852515,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T21:08:06.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over the 12 months following June 14, 2023, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Company's stockholders."}],"balance_after":12500,"derivative":{"exercise_price":13.22,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-23-037981","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000120919123037981/doc4.xml","form_type":"4"}},{"id":1893514,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-05-15T17:56:13.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023."}],"balance_after":150000,"derivative":{"exercise_price":5.7,"expiration_date":"2033-05-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-029594","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919123029594/doc4.xml","form_type":"4"}},{"id":2042177,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Common Stock","published_at":"2023-01-30T16:22:18.000Z","date":"2022-11-25","kind":"gift","acquired":false,"shares":2560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were acquired under the Issuer's stock purchase plan on November 20, 2022."}],"balance_after":10600,"source":{"system":"sec-edgar","filing":"0001209191-23-005476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919123005476/doc4.xml","form_type":"4"}},{"id":2152768,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-09-22T22:00:47.000Z","date":"2022-09-21","kind":"grant","acquired":true,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in equal monthly installments over a one year period following September 21, 2022 (the \"Grant Date\") such that the option is fully vested on the first anniversary of the Grant Date."}],"balance_after":9375,"derivative":{"exercise_price":13.54,"expiration_date":"2032-09-20","underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001209191-22-051047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000120919122051047/doc4.xml","form_type":"4"}},{"id":2152767,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-09-22T22:00:47.000Z","date":"2022-09-21","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over a three year period following September 21, 2022 (the \"Grant Date\") such that the option is fully vested on the third anniversary of the Grant Date."}],"balance_after":30000,"derivative":{"exercise_price":13.54,"expiration_date":"2032-09-20","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-22-051047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000120919122051047/doc4.xml","form_type":"4"}},{"id":2292720,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Stock Option (right to buy)","published_at":"2022-04-21T16:25:30.000Z","date":"2022-04-20","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is subject to an early exercise provision and is immediately exercisable. The underlying shares vest in accordance with the terms of the option grant."}],"balance_after":210034,"derivative":{"exercise_price":3.22,"expiration_date":"2028-02-21","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-22-025171","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919122025171/doc4.xml","form_type":"4"}},{"id":2292719,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Common Stock","published_at":"2022-04-21T16:25:30.000Z","date":"2022-04-20","kind":"exercise","acquired":true,"shares":4000,"price":3.22,"value":12880.0,"ownership":{"direct":true},"balance_after":10600,"source":{"system":"sec-edgar","filing":"0001209191-22-025171","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919122025171/doc4.xml","form_type":"4"}},{"id":2369055,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-28T16:18:28.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":104400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022."}],"balance_after":104400,"derivative":{"exercise_price":16.29,"expiration_date":"2032-02-10","underlying":"Common Stock","underlying_shares":104400},"source":{"system":"sec-edgar","filing":"0001209191-22-013557","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919122013557/doc4.xml","form_type":"4"}},{"id":2408455,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Common Stock","published_at":"2022-02-08T16:25:31.000Z","date":"2021-12-30","kind":"gift","acquired":false,"shares":2725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were acquired under the Issuer's stock purchase plan on May 20, 2021."}],"balance_after":6600,"source":{"system":"sec-edgar","filing":"0001209191-22-007754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919122007754/doc4.xml","form_type":"4"}},{"id":2594886,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-20T16:38:26.000Z","date":"2021-08-19","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is subject to an early exercise provision and is immediately exercisable. The underlying shares vest in accordance with the terms of the option grant."}],"balance_after":214034,"derivative":{"exercise_price":3.22,"expiration_date":"2028-02-21","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-052784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919121052784/doc4.xml","form_type":"4"}},{"id":2594885,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Common Stock","published_at":"2021-08-20T16:38:26.000Z","date":"2021-08-19","kind":"exercise","acquired":true,"shares":5000,"price":3.22,"value":16100.0,"ownership":{"direct":true},"balance_after":6600,"source":{"system":"sec-edgar","filing":"0001209191-21-052784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919121052784/doc4.xml","form_type":"4"}},{"id":2614872,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-04T17:39:17.000Z","date":"2021-08-03","kind":"exercise","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is subject to an early exercise provision and is immediately exercisable. The underlying shares vest in accordance with the terms of the option grant."}],"balance_after":219034,"derivative":{"exercise_price":3.22,"expiration_date":"2028-02-21","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001209191-21-049724","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919121049724/doc4.xml","form_type":"4"}},{"id":2614871,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Common Stock","published_at":"2021-08-04T17:39:17.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":4500,"price":33.8173,"value":152177.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.75 to $34.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":1600,"source":{"system":"sec-edgar","filing":"0001209191-21-049724","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919121049724/doc4.xml","form_type":"4"}},{"id":2614870,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Common Stock","published_at":"2021-08-04T17:39:17.000Z","date":"2021-08-03","kind":"exercise","acquired":true,"shares":4500,"price":3.22,"value":14490.0,"ownership":{"direct":true},"balance_after":6100,"source":{"system":"sec-edgar","filing":"0001209191-21-049724","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919121049724/doc4.xml","form_type":"4"}},{"id":2638091,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-08T19:04:06.000Z","date":"2021-07-08","kind":"exercise","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is subject to an early exercise provision and is immediately exercisable. The underlying shares vest in accordance with the terms of the option grant."}],"balance_after":223534,"derivative":{"exercise_price":3.22,"expiration_date":"2028-02-21","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001209191-21-046054","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919121046054/doc4.xml","form_type":"4"}},{"id":2638090,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Common Stock","published_at":"2021-07-08T19:04:06.000Z","date":"2021-07-08","kind":"sale","acquired":false,"shares":4500,"price":33.75,"value":151875.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020."}],"balance_after":1600,"source":{"system":"sec-edgar","filing":"0001209191-21-046054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919121046054/doc4.xml","form_type":"4"}},{"id":2638089,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Common Stock","published_at":"2021-07-08T19:04:06.000Z","date":"2021-07-08","kind":"exercise","acquired":true,"shares":4500,"price":3.22,"value":14490.0,"ownership":{"direct":true},"balance_after":6100,"source":{"system":"sec-edgar","filing":"0001209191-21-046054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919121046054/doc4.xml","form_type":"4"}},{"id":2677599,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-06-08T19:17:56.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":50337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021."}],"balance_after":50337,"derivative":{"exercise_price":28.33,"expiration_date":"2031-05-11","underlying":"Common Stock","underlying_shares":50337},"source":{"system":"sec-edgar","filing":"0001209191-21-039032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919121039032/doc4.xml","form_type":"4"}},{"id":2679365,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-07T21:36:07.000Z","date":"2021-06-04","kind":"exercise","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is subject to an early exercise provision and is immediately exercisable. The underlying shares vest in accordance with the terms of the option grant."}],"balance_after":228034,"derivative":{"exercise_price":3.22,"expiration_date":"2028-02-21","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001209191-21-038798","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919121038798/doc4.xml","form_type":"4"}},{"id":2679364,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Common Stock","published_at":"2021-06-07T21:36:07.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":4500,"price":33.75,"value":151875.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020."}],"balance_after":1600,"source":{"system":"sec-edgar","filing":"0001209191-21-038798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919121038798/doc4.xml","form_type":"4"}},{"id":2679363,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Common Stock","published_at":"2021-06-07T21:36:07.000Z","date":"2021-06-04","kind":"exercise","acquired":true,"shares":4500,"price":3.22,"value":14490.0,"ownership":{"direct":true},"balance_after":6100,"source":{"system":"sec-edgar","filing":"0001209191-21-038798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919121038798/doc4.xml","form_type":"4"}},{"id":2730185,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-04T19:22:12.000Z","date":"2021-05-03","kind":"exercise","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is subject to an early exercise provision and is immediately exercisable. The underlying shares vest in accordance with the terms of the option grant."}],"balance_after":232534,"derivative":{"exercise_price":3.22,"expiration_date":"2028-02-21","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001209191-21-030096","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919121030096/doc4.xml","form_type":"4"}},{"id":2730184,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Common Stock","published_at":"2021-05-04T19:22:12.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":4500,"price":33.75,"value":151875.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020."}],"balance_after":1600,"source":{"system":"sec-edgar","filing":"0001209191-21-030096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919121030096/doc4.xml","form_type":"4"}},{"id":2730183,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Common Stock","published_at":"2021-05-04T19:22:12.000Z","date":"2021-05-03","kind":"exercise","acquired":true,"shares":4500,"price":3.22,"value":14490.0,"ownership":{"direct":true},"balance_after":6100,"source":{"system":"sec-edgar","filing":"0001209191-21-030096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919121030096/doc4.xml","form_type":"4"}},{"id":2927532,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-31T16:25:31.000Z","date":"2020-12-08","kind":"exercise","acquired":false,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Of the 238,634 options held directly by the Reporting Person, 1,600 options were exercised as reported herein and the remaining 237,034 options continue to vest according to the terms of the option grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of shares subject to the option has been reduced by one share, which was inadvertently included in the Reporting Person's Form 3 filed on September 24, 2020."}],"balance_after":237034,"derivative":{"exercise_price":3.22,"expiration_date":"2028-02-21","underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0001209191-20-065683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919120065683/doc4.xml","form_type":"4"}},{"id":2927531,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Common Stock","published_at":"2020-12-31T16:25:31.000Z","date":"2020-12-08","kind":"exercise","acquired":true,"shares":1600,"price":3.22,"value":5152.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are subject to the terms of a lock-up agreement, dated June 23, 2020 (the \"Lock-Up Agreement\"). This report on Form 4 is in accordance with Section (v) of the Lock-Up Agreement."}],"balance_after":1600,"source":{"system":"sec-edgar","filing":"0001209191-20-065683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919120065683/doc4.xml","form_type":"4"}}]}